Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows

v3.22.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Cash flows from operating activities    
Net loss $ (20,157) $ (5,195)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 38 31
Stock-based compensation expense 919 581
Change in fair value of warrant liabilities 4,212 (5,567)
Net amortization of premium on marketable securities 97 150
Changes in operating assets and liabilities:    
Increase in prepaid expenses and other current and non-current assets (1,412) (936)
Increase in accounts payable, accrued and other current liabilities 4,536 1,877
Net cash used in operating activities (11,767) (9,059)
Cash flows from investing activities    
Proceeds from maturities of marketable securities 4,750 4,913
Net cash provided by investing activities 4,750 4,913
Cash flows from financing activities    
Proceeds from issuance of securities   57,500
Payment of financing costs of securities sold   (3,703)
Proceeds from the exercise of warrants   110
Net cash provided by financing activities   53,907
Net (decrease) increase in cash and cash equivalents (7,017) 49,761
Cash and cash equivalents at beginning of period 16,654 15,485
Cash and cash equivalents at end of period $ 9,637 $ 65,246